CIPLA LIMITED FDA Approval ANDA 077916

ANDA 077916

CIPLA LIMITED

FDA Drug Application

Application #077916

Documents

Letter2006-05-26

Application Sponsors

ANDA 077916CIPLA LIMITED

Marketing Status

None (Tentative Approval)001

Application Products

001TABLET; ORAL600MG0EFAVIRENZEFAVIRENZ

FDA Submissions

ORIG1TA2006-05-24

Submissions Property Types

ORIG1Null1

CDER Filings

CIPLA LIMITED
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77916
            [companyName] => CIPLA LIMITED
            [docInserts] => ["",""]
            [products] => [{"drugName":"EFAVIRENZ","activeIngredients":"EFAVIRENZ","strength":"600MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"EFAVIRENZ","submission":"EFAVIRENZ","actionType":"600MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.